Search Results - Ilca, F Tudor

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    TAPBPR mediates peptide dissociation from MHC class I using a leucine lever

    TAPBPR mediates peptide dissociation from MHC class I using a leucine lever by Ilca, F Tudor, Neerincx, Andreas, Hermann, Clemens, Marcu, Ana, Stevanović, Stefan, Deane, Janet E, Boyle, Louise H

    Published in eLife
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules

    Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules by Ilca, F. Tudor, Neerincx, Andreas, Wills, Mark R., de la Roche, Maike, Boyle, Louise H.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants

    Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants by Ferrari, Mathieu, Mekkaoui, Leila, Ilca, F Tudor, Akbar, Zulaikha, Bughda, Reyisa, Lamb, Katarina, Ward, Katarzyna, Parekh, Farhaan, Karattil, Rajeev, Allen, Christopher, Wu, Philip, Baldan, Vania, Mattiuzzo, Giada, Bentley, Emma M, Takeuchi, Yasuhiro, Sillibourne, James, Datta, Preeta, Kinna, Alexander, Pule, Martin, Onuoha, Shimobi C

    Published in Journal of virology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Distinct Polymorphisms in HLA Class I Molecules Govern Their Susceptibility to Peptide Editing by TAPBPR

    Distinct Polymorphisms in HLA Class I Molecules Govern Their Susceptibility to Peptide Editing by TAPBPR by Ilca, F. Tudor, Drexhage, Linnea Z., Brewin, Gemma, Peacock, Sarah, Boyle, Louise H.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry

    Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry by Horna, Pedro, Weybright, Matthew J., Ferrari, Mathieu, Jungherz, Dennis, Peng, YaYi, Akbar, Zulaikha, Tudor Ilca, F., Otteson, Gregory E., Seheult, Jansen N., Ortmann, Janosch, Shi, Min, Maciocia, Paul M., Herling, Marco, Pule, Martin A., Olteanu, Horatiu

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  6. 6
    The glycosylation status of MHC class I molecules impacts their interactions with TAPBPR

    The glycosylation status of MHC class I molecules impacts their interactions with TAPBPR by Ilca, F. Tudor, Boyle, Louise H.

    Published in Molecular immunology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency

    A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency by Leach, Adam, Ilca, F. Tudor, Akbar, Zulaikha, Ferrari, Mathieu, Bentley, Emma M., Mattiuzzo, Giada, Onuoha, Shimobi, Miller, Ami, Ali, Hanif, Rabbitts, Terence H.

    Published in Antiviral research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Enzymatic processing and MHC loading 2Peptide editing mediated by TAPBPR

    Enzymatic processing and MHC loading 2Peptide editing mediated by TAPBPR by Tudor Ilca, F., Neerincx, Andreas, Hermann, Clemens, Marcu, Ana, Stevanović, Stefan, Deane, Janet E., Boyle, Louise H.

    Published in Molecular immunology
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV2 variants

    Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV2 variants by Ferrari, Mathieu, Mekkaoui, Leila, F Tudor Ilca, Zulaikha Akbar, Bughda, Reyisa, Lamb, Katarina, Ward, Katarzyna, Parekh, Farhaan, Karattil, Rajeev, Allen, Christopher, Wu, Philip, Baldan, Vania, Mattiuzzo, Giada, Bentley, Emma M, Takeuchi, Yasuhiro, Sillibourne, James, Datta, Preeta, Kinna, Alexander, Martin, Pule, Onuoha, Shimobi C

    Published in bioRxiv
    Request full text
    Article
    Save to List
    Saved in:

Search Tools: